Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

Bullboard (TSXV:TLT)

View:
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next
Comment by blackjack0on Nov 26, 2024 10:01am

RE:RE:RE:Report on sedar

I think anyone who offers unlimited funding is going to to want control of the company and Roger is unwilling to give up control at this late stage. I think the best way for the shareholders at this ...more  
1
Discussion
Comment by Dumbeldorfwhiteon Nov 26, 2024 9:48am

RE:RE:RE:Report on sedar

Why do you think? It's not rocket science at this point. How long have GLP toxicology studies been ongoing at this point?
7
Discussion
Comment by McBullishon Nov 26, 2024 8:41am

RE:RE:Report on sedar

If I am being honest, this is what really concerns me about TLT. Whats happens should we lose investor sentiment or patience? We're so close to the line with funding its unnerving. I think if we ...more  
120
Discussion
Comment by StevenBirchon Nov 26, 2024 8:01am

RE:RE:RE:RE:RE:RE:RE:RE:Report on sedar

With U.S. Thanksgiving this week, and financials due, early December was always the most likely time for 'news' with that window probably closing around mid-December.
69
Discussion
Comment by Alamir1111on Nov 26, 2024 7:52am

RE:RE:RE:RE:RE:RE:RE:Report on sedar

Yesterday meet a young lady she is going thru cancer therapy using keytruda .She told me about the multiple treatments plus pills shes got to take and the side effects .Today I'm 1000% sure we ...more  
100
Discussion
Comment by toade1313on Nov 26, 2024 7:33am

RE:RE:RE:RE:RE:RE:RE:Report on sedar

Yes they have worked hard for them, but I prefer they are given when earned by share price improvement. Oops, another Tuesday morning come and gone with no announcement.
49
Discussion
Comment by Longholder99on Nov 26, 2024 6:06am

RE:RE:RE:RE:RE:RE:Report on sedar

I think they've worked for those options in most cases.  
54
Discussion
Comment by Infinityon Nov 26, 2024 2:23am

RE:RE:RE:RE:RE:Report on sedar

Most Directors and senior Management have been awarded stock options totalling 4.2 Million in 2015, +2.8 Million in 2017+10.0 Million in 2019, + 7.8 Million in 2022.  I may be missing a few other ...more  
117
Discussion
Comment by Beano349on Nov 25, 2024 10:29pm

RE:RE:RE:RE:Report on sedar

My hope is they buy in at this point if needed. If we can get by without them...I like to think we have 1 or 2 rounds with insiders before it disappears. 
63
Discussion
Comment by Alamir1111on Nov 25, 2024 9:58pm

RE:RE:RE:RE:RE:RE:RE:When will the next warrants become tradeable---

Warm water and Vegas  you men fl?ushed toilet water
39
Discussion
Comment by 2b7f6fabon Nov 25, 2024 9:16pm

RE:RE:RE:RE:RE:RE:When will the next warrants become tradeable---

A nice beach and warm water would be good, Vegas just so so.
58
Discussion
Comment by Legit62on Nov 25, 2024 6:32pm

RE:RE:RE:RE:Report on sedar

It really does but we have access also, the positive is they are buying i suppose, so hopefully just needed small amount to get BTD
104
Discussion
Comment by Legit62on Nov 25, 2024 4:59pm

RE:RE:RE:Report on sedar

My point was not insider trading, my point was insiders including management can participate in PPs as we all know, they are unable to buy shares open market if they have knowledge that is not made ...more  
164
Discussion
Comment by riverrrowon Nov 25, 2024 4:25pm

RE:Report on sedar

There appears to be a hard core group of about 12 investors regularly participating in the bimonthly private placements.  If it wasn't for them it would be lights out for TLT.  GLTA.
101
Discussion
Comment by CAinPlapon Nov 25, 2024 3:47pm

RE:RE:Report on sedar

QIMC is why there is no representation from Manitoba this round. Had no idea if the price jump in TLT was a setup for the PP or if the PP came because of the price jump. Chicken and egg argument that ...more  
166
Discussion
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT

Visit Facebook Visit X Visit Linked In Visit Instagram Visit Youtube



INVESTORS & MEDIA OVERVIEW FINANCIAL FILINGS PRESENTATIONS MEDIA FACT SHEETS MANAGEMENT

Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250